[Source: Research & Innovation] The European Investment Bank (EIB) is lending EUR 24 million to F2G Biotech, a research-intensive company in Austria, focusing on the discovery and development of novel drugs to treat life threatening fungal diseases.
from EUROPA - Syndicated Research News Feed https://ift.tt/2R6r0gD
via IFTTT
No comments:
Post a Comment